ConductScience.org, home

Paper28293446

Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA.

Roussou E and 1 other. Eur J Rheumatol, 2017. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA. Papers, record 28293446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28293446

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Real-life experience of using conventional disease-modifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA in comparison to spondyloarthritides other than PsA and literature review of the use of conventional DMARDs in PsA.
PubMed
Journal
Eur J Rheumatol
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2024-03-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roussou EEuthalia
2Bouraoui AAicha

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12442947Methotrexate treatment of psoriatic arthritis.Acta Derm Venereol1987https://conductscience.org/library/papers/2442947PubMed
223247553Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London.Clin Rheumatol2013https://conductscience.org/library/papers/23247553PubMed
31404123Psoriatic arthritis: clinical response and side effects to methotrexate therapy.J Rheumatol1992https://conductscience.org/library/papers/1404123PubMed
48295201Methotrexate in psoriatic polyarthritis.J Rheumatol1993https://conductscience.org/library/papers/8295201PubMed
58587077Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.J Rheumatol1995https://conductscience.org/library/papers/8587077PubMed
615188371Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.Arthritis Rheum2004https://conductscience.org/library/papers/15188371PubMed
716447233Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.Arthritis Rheum2006https://conductscience.org/library/papers/16447233PubMed
88575136Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.Clin Exp Rheumatol1995https://conductscience.org/library/papers/8575136PubMed
911465701
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
Arthritis Rheum2001https://conductscience.org/library/papers/11465701PubMed
1019033290Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.Ann Rheum Dis2009https://conductscience.org/library/papers/19033290PubMed
117699630A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.J Rheumatol1994https://conductscience.org/library/papers/7699630PubMed
1226660203Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis.Ann Rheum Dis2016https://conductscience.org/library/papers/26660203PubMed
138961906Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.Arthritis Rheum1996https://conductscience.org/library/papers/8961906PubMed
1419147614New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).Ann Rheum Dis2009https://conductscience.org/library/papers/19147614PubMed
1515492204Leflunomide in psoriasis and psoriatic arthritis: a preliminary study.Arch Dermatol2004https://conductscience.org/library/papers/15492204PubMed
1618085735Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: results from a longitudinal observational cohort.J Rheumatol2008https://conductscience.org/library/papers/18085735PubMed
1721722504
Difficulties for the detection of positive signs of sacroiliitis in spondyloarthritides by magnetic resonance imaging (MRI) in everyday clinical practice. Results from an audit circle (audit and re-audit).
Clin Exp Rheumatol2011https://conductscience.org/library/papers/21722504PubMed
1816724372Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.J Rheumatol2006https://conductscience.org/library/papers/16724372PubMed
196712754Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis.Arthritis Rheum1984https://conductscience.org/library/papers/6712754PubMed
2018030515The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.Clin Rheumatol2008https://conductscience.org/library/papers/18030515PubMed

See all 47 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
30820432The Detergent Effect of Mesalazine Interferes with Phosphatidylcholine Binding to Mucin 2.Inflamm Intest Dis2019https://conductscience.org/library/papers/30820432PubMed
30207576Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions.Arch Rheumatol2018https://conductscience.org/library/papers/30207576PubMed
29616495Role of Methotrexate in the Management of Psoriatic Arthritis.Drugs2018https://conductscience.org/library/papers/29616495PubMed
28965181Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables.Clin Exp Med2018https://conductscience.org/library/papers/28965181PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28293446

GET https://conductscience.org/api/papers/v1/28293446/references?page=2